Go to content
UR Home

Biomarker Supervised G-CSF (Filgrastim) Response in ALS Patients

URN to cite this document:
DOI to cite this document:
Johannesen, Siw Wollebæk ; Budeus, Bettina ; Peters, Sebastian ; Iberl, Sabine ; Meyer, Anne-Louise ; Kammermaier, Tina ; Wirkert, Eva ; Bruun, Tim-Henrik ; Samara, Verena C. ; Schulte-Mattler, Wilhelm ; Herr, Wolfgang ; Schneider, Armin ; Grassinger, Jochen ; Bogdahn, Ulrich
Date of publication of this fulltext: 30 Apr 2019 08:00


Objective: To evaluate safety, tolerability and feasibility of long-term treatment with Granulocyte-colony stimulating factor (G-CSF), a well-known hematopoietic stem cell factor, guided by assessment of mobilized bone marrow derived stem cells and cytokines in the serum of patients with amyotrophic lateral sclerosis (ALS) treated on a named patient basis. Methods: 36 ALS patients were treated ...


Owner only: item control page
  1. Homepage UR

University Library

Publication Server


Publishing: oa@ur.de
0941 943 -4239 or -69394

Dissertations: dissertationen@ur.de
0941 943 -3904

Research data: daten@ur.de
0941 943 -5707

Contact persons